CTi Biopharma Corp (NASDAQ:CTIC)

3.76
Delayed Data
As of 4:00pm ET
 +0.03 / +0.80%
Today’s Change
2.45
Today|||52-Week Range
4.65
+40.30%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$234.9M

Company Description

CTI BioPharma Corp. operates as a biopharmaceutical company, which focuses on the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. Its products include PIXUVRI, Pacritinib, Tosedostat and Opaxio. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.

Contact Information

CTI BioPharma Corp.
3101 Western Avenue
Seattle Washington 98121
P:(206) 282-7100
Investor Relations:
(206) 272-4345

Employees

Shareholders

Other institutional36.20%
Individual stakeholders25.20%
Mutual fund holders2.61%

Top Executives

Adam R. CraigPresident, Chief Executive Officer & Director
Bruce J. SeeleyCOO, Secretary, Chief Administrative Officer & EVP
David H. KirskeChief Financial Officer & Executive VP
Jack W. SingerEVP, Chief Scientific & Medical Officer
Ed BellInvestor Relations Contact